COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID-19). The virus invades human cells through the angiotensin-converting enzyme 2 (ACE2) receptor-driven pathway, primarily targeting th...
Main Authors: | Aneesha Achar, Chaitali Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2360 |
Similar Items
-
Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy
by: Aneesha Achar, et al.
Published: (2021-12-01) -
Quantitative analysis of magnetic resonance images for characterization of blood‐brain barrier dysfunction in dogs with brain tumors
by: Erez Hanael, et al.
Published: (2023-03-01) -
Pericyte derivation and transplantation for blood-CNS barrier reconstitution in CNS disorders
by: Hyun Woo Kim, et al.
Published: (2024-06-01) -
Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?
by: Sabrina Rahman Archie, et al.
Published: (2020-05-01) -
Nanogels as novel drug nanocarriers for CNS drug delivery
by: V. Manimaran, et al.
Published: (2023-08-01)